1[1]Piver MS,Ghamande SA,Eltabbakh GH,et al.First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix-a phase Ⅱ study.Gynecol Oncol,1999,75(3):334-337
2[2]Curtin JP,Blessing JA,Webster KD,et al.Paclitaxel,an active agent in nonsquamous carcinomas of the uterine cervix:a Gynecologic Oncology Group study.J Clin Oncol,2001,19(5):1275-1278
3[3]McGuire WP,Blessing JA,Moore D,et al.Paclitaxel has moderate activity in squamous cervix cancer:a Gynecologic Oncology Group study.J Clin Oncol,1996,14(3):792-795
4[4]Rose PG,Blessing JA,Gershenson DM,et al.Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix:a Gynecologic Oncology Group study.J Clin Oncol,1999,17(9):2676-2680
5[5]Dimopoulos MA,Papadimitriou CA,Sarris K,et al.Combination of ifosfamide,paclitaxel,and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix:a phase Ⅱ study of the Hellenic Cooperative Oncology Group.Gynecol Oncol,2002,85(3):476-482
6[6]Zanetta G,Fei F,Mangioni C.Chemotherapy with paclitaxel,ifosfamide,and cisplatin for the treatment of squamous cell cervical cancer:the experience of Monza.Semin Oncol,2000,27(1 Suppl 1:23-27
7[7]D'Agostino G,Distefano M,Greggi S,et al.Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin,paclitaxel and cisplatin.Cancer Chemother Pharmacol,2002,49(3):256-260
8[8]Cerrotta A,Gardan G,Cavina R,et al.Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix:a pilot study with intensification of dose.Eur J Gynaecol Oncol,2002,23(2:115-119
9[9]Pignata S,Frezza P,Tramontana S,et al.Phase Ⅰ study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri.Ann Oncol,2000,11(4):455-459
10[10]Ball HG,Blessing JA,Lentz SS,et al.A phase Ⅱ trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium:a Gynecologic Oncology Group study.Gynecol Oncol,1996,62(2:278-281
